[Analysis of factors related to prognosis in patients with chronic hepatitis type C--clinical laboratory data].
Matsumoto
Akihiro
A
Second Department of Internal Medicine, Shinshu University School of Medicine.
Tanaka
Eiji
E
Kiyosawa
Kendo
K
D015415:Biomarkers / Q000032:analysis; D014408:Biomarkers, Tumor / Q000032:analysis; D006528:Carcinoma, Hepatocellular / Q000175:diagnosis / Q000209:etiology; D019698:Hepatitis C, Chronic / Q000150:complications; D006801:Humans; D008103:Liver Cirrhosis / Q000175:diagnosis / Q000209:etiology; D008113:Liver Neoplasms / Q000175:diagnosis / Q000209:etiology; D010976:Platelet Count; D011379:Prognosis; D011498:Protein Precursors / Q000032:analysis; D011516:Prothrombin / Q000032:analysis; D012306:Risk; D012709:Serum Albumin / Q000032:analysis; D012720:Severity of Illness Index; D000509:alpha-Fetoproteins / Q000032:analysis
D015415:Biomarkers; D014408:Biomarkers, Tumor; D011498:Protein Precursors; D012709:Serum Albumin; D000509:alpha-Fetoproteins; C008208:acarboxyprothrombin; D011516:Prothrombin